Business Standard

Easy to store and cheaper, Oxford's Covid shot may be vaccine for the world

Astra vaccine accounts for more than 40% of supplies going to low- and middle-income nations

Coronavirus, vaccine, covid, drugs, clinical trials
Premium

UK’s approval may soon be followed by other countries, including India, though the European Union and the US are not expected to act on the vaccine anytime soon.

Agencies
AstraZeneca and Oxford’s vaccine developed against Covid-19 can be stored, transported, and handled at normal refrigerator temperatures, making it an attractive option for countries around the world vis-a-vis its counterparts Pfizer and Moderna. 
It is for these reasons that the vaccine proves to be cheaper and easier to administer. 

UK’s approval may soon be followed by other countries, including India, though the European Union and the US are not expected to act on the vaccine anytime soon. AstraZeneca said Wednesday it is seeking an emergency-use listing from the World Health Organization so that the shot can be made available to low- and

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in